IPO Timeline
Broker Results (T-2)
2021-09-21
Some brokers release in afternoon
Grey Market (T-1)
2021-09-23
Afternoon
HKEX Allotment (T-1)
2021-09-23
Evening
Registrar Allotment (T-1)
2021-09-23
Evening
Listing Day (T)
2021-09-24
First day of trading
Company Overview
| Stock Name | 堃博醫療控股有限公司 - B |
|---|---|
| Stock Code | 02216 |
| Company Full Name | 堃博醫療控股有限公司 - B |
| Industry | 醫療保健 |
| Principal Activities | 主要從事醫療器械及耗材的研發、制造及商業化，專注於開發用於肺病導航及診療的技術和產品。 |
| Listing Date | 2021-09-24 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國浙江省杭州市濱江區西興街道江陵路88號8幢8層801室 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.broncus.com |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 18.70 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 42.4% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 167,093,850 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 15.0 |
|---|---|
| First Day Open | HK$ 18.0 |
| First Day Change | -19.79% |
| First Day Volume | 19821500.0 |
| First Day Turnover | 318630000.0 |
Use of Proceeds
| Use of Proceeds | 1、49.9%（或約774.8百萬港元）分配予我們的核心產品； 2、18.5%（或約287.4百萬港元）分配予我們的其他產品及候選產品； 3、9.2%（或約143.0百萬港元）將用于為繼續擴大我們生產廠房的生產線提供資金； 4、13.2%（或約204.3百萬港元）將用于為通過潛在收購持續擴大產品組合提供資金； 5、9.2%（或約143.0百萬港元）將用于營運資金及其他一般公司用途。 |
|---|
Underwriting Syndicate
Joint Sponsors (2)
高盛（亚洲）有限责任公司 CE ACC536
海通国际资本有限公司 CE ADQ859
Overall Coordinators (3)
高盛（亚洲）有限责任公司 CE ACC536
海通国际证券有限公司 CE AAF806
Credit Suisse (Hong Kong) Limited CE AAO017
Joint Bookrunners (7)
高盛（亚洲）有限责任公司 CE ACC536
海通国际证券有限公司 CE AAF806
Credit Suisse (Hong Kong) Limited CE AAO017
招银国际融资有限公司 CE AVM940
华泰金融控股（香港）有限公司 CE AOK809
兴证国际融资有限公司 CE BAK956
信银（香港）资本有限公司 CE AEQ982
Joint Lead Managers (7)
高盛（亚洲）有限责任公司 CE ACC536
海通国际证券有限公司 CE AAF806
Credit Suisse (Hong Kong) Limited CE AAO017
招银国际融资有限公司 CE AVM940
华泰金融控股（香港）有限公司 CE AOK809
兴证国际融资有限公司 CE BAK956
信银（香港）资本有限公司 CE AEQ982
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | Artisan China Post-Venture Master Fund LP | 38,858,600 HKD | — | 2.30% | — | 6 months | 2022-03-24 |
| 2 | Cephei | 77,717,200 HKD | — | 4.70% | — | 6 months | 2022-03-24 |
| 3 | Emerging Markets Healthcare Partners LLC | 15,539,700 HKD | — | 0.90% | — | 6 months | 2022-03-24 |
| 4 | Lake Bleu Prime Healthcare Master Fund Limited | 155,434,400 HKD | — | 9.30% | — | 6 months | 2022-03-24 |
| 5 | Snow Lake China Master Fund, Ltd. | 77,717,200 HKD | — | 4.70% | — | 6 months | 2022-03-24 |
| 6 | Springhill Master Fund Limited | 38,858,600 HKD | — | 2.30% | — | 6 months | 2022-03-24 |
| 7 | Summer Healthcare Fund, L.P. | 77,717,200 HKD | — | 4.70% | — | 6 months | 2022-03-24 |
| 8 | The Valliance Fund | 23,309,550 HKD | — | 1.40% | — | 6 months | 2022-03-24 |
| 9 | UBS Asset Management (Singapore) Ltd. | 194,293,000 HKD | — | 11.60% | — | 6 months | 2022-03-24 |
| 10 | Worldwide Healthcare Partners LLC | 7,769,850 HKD | — | 0.50% | — | 6 months | 2022-03-24 |
Directors & Management
| Chairman | 徐宏 |
|---|---|
| Company Secretary | 孫嘉恩 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | Qiming Venture Partners IV L.P.(15.46%);Dinova Healthcare Gamma Fund (USD) L.P.(8.3%);浙江德諾瑞盈創業投資合夥企業(有限合夥)(6.29%);清池資本(香港)(5.14%) |
|---|
IPO Timeline
